Placental Growth Factor as a Protective Paracrine Effector in the Heart

Trends in Cardiovascular Medicine

Volumn 21, Issue 8, 2011, Pages 220-224

  Accornero, Federica ^a   Molkentin, Jeffery D ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACENTAL GROWTH FACTOR;

ANGIOGENESIS; HEART FUNCTION; HEART MUSCLE CELL; HEART STRESS; HEART VENTRICLE HYPERTROPHY; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARDIOMEGALY; HUMANS; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PREGNANCY PROTEINS; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84865166096     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.05.014     Document Type: Review

References (32)

1. Accornero F., van Berlo J.H., Benard M.J., et al. Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 2011, 109:272-280.
2. Autiero M., Waltenberger J., Communi D., et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003, 9:936-943.
3. Baudino T.A., Carver W., Giles W., Borg T.K. Cardiac fibroblasts: Friend or foe?. Am J Physiol Heart Circ Physiol 2006, 291:H1015-H1026.
4. Bowers S.L., Borg T.K., Baudino T.A. The dynamics of fibroblast-myocyte-capillary interactions in the heart. Ann N Y Acad Sci 2010, 1188:143-152.
5. Carmeliet P., Moons L., Luttun A., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001, 7:575-583.
6. Carnevale D., Cifelli G., Mascio G., et al. Placental growth factor regulates cardiac inflammation through the tissue inhibitor of metalloproteinases-3/tumor necrosis factor-α-converting enzyme axis: Crucial role for adaptive cardiac remodeling during cardiac pressure overload. Circulation 2011, 124:1337-1350.
7. Chintalgattu V., Nair D.M., Katwa L.C. Cardiac myofibroblasts: A novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 2003, 35:277-286.
8. Clauss M., Weich H., Breier G., et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996, 271:17629-17634.
9. Gigante B., Tarsitano M., Cimini V., et al. Placenta growth factor is not required for exercise-induced angiogenesis. Angiogenesis 2004, 7:277-284.
10. Giordano F.J., Gerber H.P., Williams S.P., et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 2001, 98:5780-5785.
11. Herz K., Heinemann J.C., Hesse M., et al. Live monitoring of small vessels during development and disease using the flt-1 promoter element. Basic Res Cardiol 2012, 107:257.
12. Ii M., Nishimura H., Iwakura A., et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 2005, 111:1114-1120.
13. Iwama H., Uemura S., Naya N., et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol 2006, 47:1559-1567.
14. Iwasaki H., Kawamoto A., Tjwa M., et al. PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors. PLoS ONE 2011, 6:e24872.
15. Jiang X., Khan M.A., Tian W., et al. Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest 2011, 121:2336-2349.
16. Kakkar R., Lee R.T. Intramyocardial fibroblast myocyte communication. Circ Res 2010, 106:47-57.
17. Kaplan R.N., Riba R.D., Zacharoulis S., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827.
18. Kehat I., Molkentin J.D. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 2010, 122:2727-2735.
19. Kolakowski S., Berry M.F., Atluri P., et al. Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy. J Card Surg 2006, 21:559-564.
20. Li B., Sharpe E.E., Maupin A.B., et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006, 20:20. 14951497.
21. Maglione D., Guerriero V., Viglietto G., et al. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 1991, 88:9267-9271.
22. Nakamura T., Funayama H., Kubo N., et al. Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy. Int J Cardiol 2009, 131:186-191.
23. Ottaviano F.G., Yee K.O. Communication signals between cardiac fibroblasts and cardiac myocytes. J Cardiovasc Pharmacol 2011, 57:513-521.
24. Park J.E., Chen H.H., Winer J., et al. Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994, 269:25646-25654.
25. Persico M.G., Vincenti V., DiPalma T. Structure, expression and receptor-binding properties of placenta growth factor (PlGF). Curr Top Microbiol Immunol 1999, 237:31-40.
26. Pipp F., Heil M., Issbrucker K., et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: Evidence for a monocyte-mediated mechanism. Circ Res 2003, 92:378-385.
27. Roncal C., Buysschaert I., Chorianopoulos E., et al. Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance. J Pathol 2008, 216:236-244.
28. Sabbah H.N., Sharov V.G., Lesch M., Goldstein S. Progression of heart failure: A role for interstitial fibrosis. Mol Cell Biochem 1995, 147:29-34.
29. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006, 39:469-478.
30. Souders C.A., Bowers S.L., Baudino T.A. Cardiac fibroblast: The renaissance cell. Circ Res 2009, 105:1164-1176.
31. Tsuruda T., Imamura T., Hatakeyama K., et al. Stromal cell biology: A way to understand the evolution of cardiovascular diseases. Circ J 2010, 74:1042-1050.
32. Walsh K., Shiojima I. Cardiac growth and angiogenesis coordinated by intertissue interactions. J Clin Invest 2007, 117:3176-3179.